Amgen (AMGN) |
United States |
$138.688B |
15.98 |
CSL (CSLLY) |
Australia |
$86.180B |
0.00 |
Gilead Sciences (GILD) |
United States |
$83.411B |
10.33 |
Vertex Pharmaceuticals (VRTX) |
United States |
$57.362B |
58.55 |
Biogen (BIIB) |
United States |
$54.022B |
9.27 |
Illumina (ILMN) |
United States |
$47.012B |
51.58 |
Regeneron Pharmaceuticals (REGN) |
United States |
$40.442B |
17.71 |
Alexion Pharmaceuticals (ALXN) |
United States |
$23.771B |
11.74 |
Incyte (INCY) |
United States |
$20.245B |
46.99 |
Seattle Genetics (SGEN) |
United States |
$20.080B |
0.00 |
SINO PHARMACEUT (SBMFF) |
Hong Kong, SAR China |
$17.057B |
0.00 |
Genmab (GNMSF) |
Denmark |
$14.761B |
65.20 |
BioMarin Pharmaceutical (BMRN) |
United States |
$14.384B |
0.00 |
Alnylam Pharmaceuticals (ALNY) |
United States |
$13.850B |
0.00 |
Galapagos (GLPG) |
Belgium |
$11.489B |
29.60 |
Exact Sciences (EXAS) |
United States |
$10.855B |
0.00 |
QIAGEN (QGEN) |
Netherlands |
$9.422B |
30.72 |
BeiGene (BGNE) |
Cayman Islands |
$9.086B |
0.00 |
Bio-Techne Corp (TECH) |
United States |
$8.300B |
55.55 |
Sarepta Therapeutics (SRPT) |
United States |
$8.197B |
0.00 |
Amarin (AMRN) |
Ireland |
$7.791B |
0.00 |
ACADIA Pharmaceuticals (ACAD) |
United States |
$7.775B |
0.00 |
Guardant Health (GH) |
United States |
$6.910B |
0.00 |
Moderna (MRNA) |
United States |
$6.878B |
0.00 |
Medicines (MDCO) |
United States |
$6.689B |
0.00 |
Reata Pharmaceuticals (RETA) |
United States |
$6.041B |
0.00 |
Horizon Therapeutics Public (HZNP) |
Ireland |
$5.967B |
15.17 |
ARGENX SE-ADR (ARGX) |
Netherlands |
$5.702B |
0.00 |
Exelixis (EXEL) |
United States |
$5.211B |
14.66 |
BioNTech SE (BNTX) |
Germany |
$5.089B |
0.00 |
Ascendis Pharma (ASND) |
Denmark |
$4.626B |
0.00 |
Repligen (RGEN) |
United States |
$4.603B |
83.42 |
China Biologic Products (CBPO) |
China |
$4.590B |
25.86 |
Bluebird Bio (BLUE) |
United States |
$4.462B |
0.00 |
Spark Therapeutics (ONCE) |
United States |
$4.225B |
0.00 |
Mirati Therapeutics (MRTX) |
United States |
$4.133B |
0.00 |
MorphoSys AG (MOR) |
Germany |
$4.095B |
0.00 |
Intercept Pharmaceuticals (ICPT) |
United States |
$3.921B |
0.00 |
CRISPR Therapeutics AG (CRSP) |
Switzerland |
$3.903B |
0.00 |
Blueprint Medicines (BPMC) |
United States |
$3.669B |
0.00 |
Adaptive Biotechnologies (ADPT) |
United States |
$3.649B |
0.00 |
Immunomedics (IMMU) |
United States |
$3.577B |
0.00 |
Alkermes (ALKS) |
Ireland |
$3.253B |
0.00 |
Genmab (GMAB) |
Denmark |
$3.105B |
6.40 |
MyoKardia (MYOK) |
United States |
$3.103B |
0.00 |
UniQure (QURE) |
Netherlands |
$2.817B |
0.00 |
Halozyme Therapeutics (HALO) |
United States |
$2.793B |
0.00 |
NeoGenomics (NEO) |
United States |
$2.722B |
144.83 |
Emergent Biosolutions (EBS) |
United States |
$2.714B |
26.96 |
Acceleron Pharma (XLRN) |
United States |
$2.584B |
0.00 |
Amicus Therapeutics (FOLD) |
United States |
$2.553B |
0.00 |
Ultragenyx Pharmaceutical (RARE) |
United States |
$2.472B |
0.00 |
Zai Lab (ZLAB) |
China |
$2.392B |
0.00 |
Arena Pharmaceuticals (ARNA) |
United States |
$2.330B |
5.42 |
RA PHARMCTL INC (RARX) |
United States |
$2.208B |
0.00 |
Insmed (INSM) |
United States |
$2.016B |
0.00 |
Myriad Genetics (MYGN) |
United States |
$1.910B |
28.21 |
Ligand Pharmaceuticals (LGND) |
United States |
$1.843B |
35.45 |
Dicerna Pharmaceuticals (DRNA) |
United States |
$1.814B |
0.00 |
Denali Therapeutics (DNLI) |
United States |
$1.746B |
0.00 |
Momenta Pharmaceuticals (MNTA) |
United States |
$1.667B |
0.00 |
Akcea Therapeutics (AKCA) |
United States |
$1.654B |
0.00 |
Zymeworks (ZYME) |
Canada |
$1.651B |
0.00 |
REGENXBIO (RGNX) |
United States |
$1.602B |
0.00 |
Editas Medicine (EDIT) |
United States |
$1.559B |
0.00 |
Nabriva Therapeutics AG (NBRV) |
Ireland |
$1.465B |
0.00 |
Epizyme (EPZM) |
United States |
$1.393B |
0.00 |
Sangamo Therapeutics (SGMO) |
United States |
$1.344B |
0.00 |
Alector (ALEC) |
United States |
$1.336B |
0.00 |
Innoviva (INVA) |
United States |
$1.314B |
3.87 |
Arvinas (ARVN) |
United States |
$1.274B |
0.00 |
Athenex (ATNX) |
United States |
$1.274B |
0.00 |
Coherus BioSciences (CHRS) |
United States |
$1.232B |
0.00 |
Principia Biopharma (PRNB) |
United States |
$1.193B |
0.00 |
Zealand Pharma (ZLDPF) |
Denmark |
$1.129B |
0.00 |
WAVE Life Sciences (WVE) |
Singapore |
$1.114B |
0.00 |
Orchard Therapeutics (ORTX) |
United Kingdom |
$1.104B |
0.00 |
Fate Therapeutics (FATE) |
United States |
$1.026B |
0.00 |
Zealand Pharma (ZEAL) |
Denmark |
$0.988B |
0.00 |
Precision BioSciences (DTIL) |
United States |
$0.940B |
0.00 |
Pharming Group (PHGUF) |
Netherlands |
$0.926B |
0.00 |
ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.921B |
0.00 |
Vanda Pharmaceuticals (VNDA) |
United States |
$0.913B |
7.67 |
Codexis (CDXS) |
United States |
$0.896B |
0.00 |
Achillion Pharmaceuticals (ACHN) |
United States |
$0.861B |
0.00 |
BAVARIAN NORDIC (BVNRY) |
Denmark |
$0.846B |
0.00 |
Intellia Therapeutics (NTLA) |
United States |
$0.842B |
0.00 |
Vericel (VCEL) |
United States |
$0.820B |
305.83 |
MiMedx (MDXG) |
United States |
$0.818B |
0.00 |
Anika Therapeutics (ANIK) |
United States |
$0.814B |
26.41 |
Twist Bioscience (TWST) |
United States |
$0.767B |
0.00 |
Heska (HSKA) |
United States |
$0.739B |
188.92 |
Revance Therapeutics (RVNC) |
United States |
$0.719B |
0.00 |
DBV Technologies S.A (DBVT) |
France |
$0.712B |
0.00 |
ANI Pharmaceuticals (ANIP) |
United States |
$0.710B |
12.10 |
Adverum Biotechnologies (ADVM) |
United States |
$0.681B |
0.00 |
Mesoblast (MESO) |
Australia |
$0.670B |
0.00 |
Cara Therapeutics (CARA) |
United States |
$0.646B |
0.00 |
UROGEN PHARMA (URGN) |
United States |
$0.642B |
0.00 |
Cellectis S.A (CLLS) |
France |
$0.618B |
0.00 |
Autolus Therapeutics (AUTL) |
United Kingdom |
$0.593B |
0.00 |
GENFIT S.A (GNFT) |
France |
$0.592B |
0.00 |
Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.590B |
0.00 |
BioDelivery Sciences (BDSI) |
United States |
$0.581B |
0.00 |
Cytokineticsorporated (CYTK) |
United States |
$0.580B |
0.00 |
PHARMA MAR SA (PHMMF) |
Spain |
$0.564B |
0.00 |
Agenus (AGEN) |
United States |
$0.559B |
0.00 |
Retrophin (RTRX) |
United States |
$0.555B |
0.00 |
AC Immune SA (ACIU) |
Switzerland |
$0.553B |
12.80 |
Intra-Cellular Therapies (ITCI) |
United States |
$0.542B |
0.00 |
Sorrento Therapeutics (SRNE) |
United States |
$0.536B |
0.00 |
Kadmon Holdings (KDMN) |
United States |
$0.530B |
0.00 |
OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$0.514B |
0.00 |
Prothena (PRTA) |
Ireland |
$0.495B |
0.00 |
Stemline Therapeutics (STML) |
United States |
$0.492B |
0.00 |
Clovis Oncology (CLVS) |
United States |
$0.486B |
0.00 |
Dynavax Technologies (DVAX) |
United States |
$0.477B |
0.00 |
Sinovac Biotech (SVA) |
China |
$0.460B |
0.00 |
Lexicon Pharmaceuticals (LXRX) |
United States |
$0.450B |
3.11 |
Merus (MRUS) |
Netherlands |
$0.390B |
0.00 |
AnaptysBio (ANAB) |
United States |
$0.386B |
0.00 |
Bellus Health (BLU) |
Canada |
$0.384B |
0.00 |
AMAG Pharmaceuticals (AMAG) |
United States |
$0.363B |
0.00 |
Xenon Pharmaceuticals (XENE) |
Canada |
$0.359B |
0.00 |
Arcus Biosciences (RCUS) |
United States |
$0.357B |
0.00 |
Starpharma Holdings (SPHRY) |
Australia |
$0.343B |
0.00 |
PDL BioPharma (PDLI) |
United States |
$0.341B |
8.54 |
OSMOTICA PHARM (OSMT) |
United States |
$0.339B |
0.00 |
Pfenex (PFNX) |
United States |
$0.336B |
0.00 |
Cellular Biomedicine (CBMG) |
United States |
$0.336B |
0.00 |
Avid Bioservices (CDMO) |
United States |
$0.318B |
0.00 |
Geron (GERN) |
United States |
$0.304B |
0.00 |
Gritstone Oncology (GRTS) |
United States |
$0.301B |
0.00 |
Kamada (KMDA) |
Israel |
$0.298B |
8.71 |
Kindred Biosciences (KIN) |
United States |
$0.297B |
0.00 |
Puma Biotechnology (PBYI) |
United States |
$0.290B |
0.00 |
CytomX Therapeutics (CTMX) |
United States |
$0.279B |
0.00 |
Compugen (CGEN) |
Israel |
$0.276B |
0.00 |
Albireo Pharma (ALBO) |
United States |
$0.271B |
0.00 |
Cel-Sci (CVM) |
United States |
$0.270B |
0.00 |
Cue Biopharma (CUE) |
United States |
$0.261B |
0.00 |
Seres Therapeutics (MCRB) |
United States |
$0.258B |
0.00 |
MannKind (MNKD) |
United States |
$0.246B |
0.00 |
ADMA Biologics Inc (ADMA) |
United States |
$0.245B |
0.00 |
Syndax Pharmaceuticals (SNDX) |
United States |
$0.239B |
0.00 |
Scholar Rock Holding (SRRK) |
United States |
$0.237B |
0.00 |
Inovio Pharmaceuticals (INO) |
United States |
$0.233B |
0.00 |
Sutro Biopharma (STRO) |
United States |
$0.231B |
0.00 |
Senesco Technologies (ELOX) |
United States |
$0.229B |
0.00 |
Biofrontera AG (BFRA) |
Germany |
$0.226B |
0.00 |
Aeglea BioTherapeutics (AGLE) |
United States |
$0.224B |
0.00 |
ChromaDex (CDXC) |
United States |
$0.223B |
0.00 |
Spero Therapeutics (SPRO) |
United States |
$0.219B |
0.00 |
Theratechnologies (THTX) |
Canada |
$0.218B |
0.00 |
Exicure (XCUR) |
United States |
$0.216B |
0.00 |
XOMA (XOMA) |
United States |
$0.213B |
0.00 |
Protagonist Therapeutics (PTGX) |
United States |
$0.208B |
0.00 |
Athersys (ATHX) |
United States |
$0.204B |
0.00 |
POXEL SA FRANCE (PXXLF) |
France |
$0.203B |
0.00 |
Mersana Therapeutics (MRSN) |
United States |
$0.199B |
0.00 |
Syros Pharmaceuticals (SYRS) |
United States |
$0.197B |
0.00 |
Proteostasis Therapeutics (PTI) |
United States |
$0.194B |
0.00 |
Pieris Pharmaceuticals (PIRS) |
United States |
$0.189B |
0.00 |
Palatin Technologies (PTN) |
United States |
$0.181B |
4.95 |
IVERIC Bio (ISEE) |
United States |
$0.179B |
0.00 |
Affimed (AFMD) |
Germany |
$0.176B |
0.00 |
Aquinox Pharmaceuticals (NLTX) |
United States |
$0.170B |
0.00 |
ARAVIVE, INC (ARAV) |
United States |
$0.168B |
0.00 |
Dyadic (DYAI) |
United States |
$0.162B |
0.00 |
Bicycle Therapeutics (BCYC) |
United Kingdom |
$0.159B |
0.00 |
EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.159B |
0.00 |
CorMedix Inc (CRMD) |
United States |
$0.157B |
0.00 |
Fortress Biotech (FBIO) |
United States |
$0.151B |
0.00 |
Cerecor (CERC) |
United States |
$0.149B |
0.00 |
Alcobra (ARCT) |
United States |
$0.149B |
0.00 |
NantKwest (NK) |
United States |
$0.148B |
0.00 |
VBI Vaccines (VBIV) |
United States |
$0.144B |
0.00 |
Abeona Therapeutics (ABEO) |
United States |
$0.141B |
0.00 |
Five Prime Therapeutics (FPRX) |
United States |
$0.137B |
0.00 |
Aptinyx (APTX) |
United States |
$0.134B |
0.00 |
Newron Pharmaceuticals SpA (NWPHF) |
Italy |
$0.134B |
0.00 |
Northwest Biotherapeutics (NWBO) |
United States |
$0.133B |
0.00 |
Arsanis (XFOR) |
United States |
$0.133B |
0.00 |
TELA Bio (TELA) |
United States |
$0.133B |
0.00 |
Prometic Life Sciences (LMNL) |
Canada |
$0.131B |
0.00 |
Nymox Pharmaceutical (NYMX) |
Canada |
$0.130B |
0.00 |
Windtree Therapeutics (WINT) |
United States |
$0.129B |
0.00 |
Enzo Biochem (ENZ) |
United States |
$0.127B |
0.00 |
Arbutus Biopharma (ABUS) |
Canada |
$0.126B |
0.00 |
SESEN BIO, INC (SESN) |
United States |
$0.126B |
0.00 |
Nicox SA (NICXF) |
France |
$0.124B |
0.00 |
AVEO Pharmaceuticals (AVEO) |
United States |
$0.123B |
0.00 |
Novavax (NVAX) |
United States |
$0.121B |
0.00 |
BioTime (LCTX) |
United States |
$0.120B |
6.15 |
Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.119B |
0.00 |
Celyad SA (CYAD) |
Belgium |
$0.119B |
0.00 |
Paratek Pharmaceuticals (PRTK) |
United States |
$0.100B |
0.00 |
Menlo Therapeutics (MNLO) |
United States |
$0.099B |
0.00 |
Emmaus Life Sciences (EMMA) |
United States |
$0.096B |
0.00 |
Strongbridge Biopharma (SBBP) |
United States |
$0.096B |
2.57 |
Aduro Biotech (ADRO) |
United States |
$0.095B |
0.00 |
Verastem (VSTM) |
United States |
$0.093B |
0.00 |
PHASEBIO PHARMA (PHAS) |
United States |
$0.093B |
0.00 |
Adocia (ADOCY) |
France |
$0.086B |
0.00 |
Antibe Therapeutics (ATBPF) |
Canada |
$0.084B |
0.00 |
Acorda Therapeutics (ACOR) |
United States |
$0.082B |
0.00 |
VTv Therapeutics (VTVT) |
United States |
$0.081B |
0.00 |
OvaScience (MLND) |
United States |
$0.081B |
0.00 |
ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.080B |
0.00 |
Liquidia Technologies (LQDA) |
United States |
$0.077B |
0.00 |
ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.076B |
0.00 |
Synlogic (SYBX) |
United States |
$0.074B |
0.00 |
Vaccinex (VCNX) |
United States |
$0.074B |
0.00 |
Selecta Biosciences (SELB) |
United States |
$0.072B |
0.00 |
Catabasis Pharmaceuticals (CATB) |
United States |
$0.069B |
0.00 |
Clearside Biomedical (CLSD) |
United States |
$0.067B |
0.00 |
Trevena (TRVN) |
United States |
$0.066B |
0.00 |
Prima BioMed (IMMP) |
Australia |
$0.066B |
0.00 |
Organovo Holdings (ONVO) |
United States |
$0.064B |
0.00 |
Curis (CRIS) |
United States |
$0.061B |
0.00 |
Catalyst Biosciences (CBIO) |
United States |
$0.061B |
0.00 |
Pluristem Therapeutics (PSTI) |
Israel |
$0.059B |
0.00 |
NewLink Genetics (NLNK) |
United States |
$0.059B |
0.00 |
Merrimack Pharmaceuticals (MACK) |
United States |
$0.058B |
0.00 |
Spring Bank Pharmaceuticals (SBPH) |
United States |
$0.057B |
0.00 |
Applied Genetic Technologies (AGTC) |
United States |
$0.054B |
0.00 |
Idera Pharmaceuticals (IDRA) |
United States |
$0.051B |
0.00 |
Aridis Pharmaceuticals (ARDS) |
United States |
$0.047B |
0.00 |
AquaBounty Technologies (AQB) |
United States |
$0.046B |
0.00 |
Checkpoint Therapeutics (CKPT) |
United States |
$0.046B |
0.00 |
AIT Therapeutics (XAIR) |
United States |
$0.045B |
0.00 |
Protalix BioTherapeutics (PLX) |
Israel |
$0.045B |
0.00 |
Vascular Biogenics (VBLT) |
Israel |
$0.045B |
0.00 |
Orgenesis (ORGS) |
United States |
$0.042B |
2.72 |
Celldex Therapeutics (CLDX) |
United States |
$0.041B |
0.00 |
AmpliPhi Biosciences (ARMP) |
United States |
$0.041B |
0.00 |
Sunesis Pharmaceuticals (SNSS) |
United States |
$0.039B |
0.00 |
DiaMedica Therapeutics (DMAC) |
United States |
$0.035B |
0.00 |
Oncobiologics (OTLK) |
United States |
$0.035B |
0.00 |
Stellar Biotechnologies (EDSA) |
Canada |
$0.035B |
0.00 |
Alimera Sciences (ALIM) |
United States |
$0.034B |
0.00 |
Evogene (EVGN) |
Israel |
$0.033B |
0.00 |
Celsion (CLSN) |
United States |
$0.033B |
0.00 |
VIVUS (VVUS) |
United States |
$0.030B |
0.00 |
Fibrocell Science Inc (FCSC) |
United States |
$0.029B |
16.61 |
Bionano Genomics (BNGO) |
United States |
$0.029B |
0.00 |
BioCardia (BCDA) |
United States |
$0.028B |
0.00 |
Caladrius Biosciences (CLBS) |
United States |
$0.027B |
0.00 |
Aptevo Therapeutics (APVO) |
United States |
$0.027B |
0.00 |
Novogen (KZIA) |
Australia |
$0.026B |
0.00 |
Apricus Biosciences (SEEL) |
United States |
$0.026B |
0.00 |
INNOVATE BIOPHARMACEUTICALS, INC (INNT) |
United States |
$0.026B |
0.00 |
Aerpio Pharmaceuticals (ARPO) |
United States |
$0.024B |
0.00 |
Entera Bio (ENTX) |
Israel |
$0.024B |
0.00 |
PLANET GREEN HOLDINGS CORP (PLAG) |
China |
$0.022B |
0.00 |
Soligenix (SNGX) |
United States |
$0.022B |
0.00 |
Unum Therapeutics (UMRX) |
United States |
$0.021B |
0.00 |
Signal Genetics (MGEN) |
United States |
$0.019B |
0.00 |
CollPlant Holdings (CLGN) |
Israel |
$0.019B |
0.00 |
VistaGen Therapeutics (VTGN) |
United States |
$0.019B |
0.00 |
AEterna Zentaris (AEZS) |
United States |
$0.017B |
0.00 |
Pulmatrix (PULM) |
United States |
$0.017B |
0.00 |
Aytu Bioscience (AYTU) |
United States |
$0.017B |
0.00 |
TOCAGEN INC (TOCA) |
United States |
$0.015B |
0.00 |
IMMURON (IMRN) |
Australia |
$0.014B |
0.00 |
MYOS RENS Technology (MYOS) |
United States |
$0.014B |
0.00 |
Prana Biotechnology (ATHE) |
Australia |
$0.013B |
0.00 |
Advaxis (ADXS) |
United States |
$0.011B |
0.00 |
TrovaGene (TROV) |
United States |
$0.010B |
0.00 |
Titan Pharmaceuticals (TTNP) |
United States |
$0.010B |
0.00 |
TRACON Pharmaceuticals (TCON) |
United States |
$0.010B |
0.00 |
Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.009B |
0.00 |
IBio (IBIO) |
United States |
$0.009B |
0.00 |
Cesca Therapeutics (THMO) |
United States |
$0.008B |
0.00 |
Cleveland BioLabs (CBLI) |
United States |
$0.008B |
0.00 |
Genetic Technologies (GENE) |
Australia |
$0.008B |
0.00 |
Benitec Biopharma (BNTC) |
Australia |
$0.007B |
0.00 |
BioPharmX (BPMX) |
United States |
$0.006B |
0.00 |
Neuralstem (SNCA) |
United States |
$0.004B |
0.00 |